Siste oppdatering :
22/08/2024
Infostab
Lister
Sammendrag
Søk etter kompatibilitet
Y-side kompatibilitetstabell
Referanser
Forskerteamet
valistab
plakat
Tilkoblinger
sponsorer
Forfatter
Instruksjon
Nyhetsbrev
Ursodesoxycholique acid
Kjemisk struktur
Referanser : Ursodesoxycholique acid
Type
publikasjon
2410
Journal
Johnson CE, Streetman DD.
Stability of oral suspensions of ursodiol made from tablets
Am J Health-Syst Pharm 2002 ; 59: 361-363.
2449
Journal
Johnson CE, Nesbitt J.
Stability of ursodiol in an extemporaneously compounded oral liquid
Am J Health-Syst Pharm 1995 ; 52: 1798-1800.
3782
Journal
A. Santove?a, E. S?nchez-Negr?n, L. Charola, M. Llabr?s, J.B. Fari?a
Study of quality and stability of ursodeoxycholic acid formulations for oral pediatric administration
Int J Pharm 2014 , 477, 1-2 : 32-38.
4177
Journal
Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Int J Pharm Compound 2018 ;22,6:516-526
4214
Journal
Pramar Y.V, Mandal T.K, Bostanian L.A, Nguyen A.TQ, Miller V, Morris T.C, Graves R.A.
Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt.
Int J Pharm Compound 2019 ;23,1:70-76
4498
Journal
Hausherr A, Roessle C, Pinet E, Vasseur V, Abarou T, Benakouche S, Bourdon O, Storme T.
Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/mL ursodesoxycholic acid for newborns.
Pharmaceutical Technology in Hospital Pharmacy 2020
Mentions Légales